SwedenBIO and the Swedish Medical Products Agency has launched Sweden’s first dialogue forum covering clinical research. This forum is intended to be a bridge between regulatory and small and medium enterprises (SMEs) in the pharma and medtech industry, in order to improve knowledge transfer, factilitate an open dialogue, and improve collaboration. Ultimately, this initiative will accelerate clinical research, ensuring that Sweden remains attractive as a life science nation.
As part of this program, a webinar series will be offered every Tuesday from May 24th to June 14th. The webinars will cover the regulatory framework for pharmaceuticals and medical device development, including clinical development.